These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3285542)

  • 61. Graft rejection following T lymphocyte depleted bone marrow transplantation with two different TBI regimens.
    Iriondo A; Hermosa V; Richard C; Conde E; Bello C; Garijo J; Baro J; Zubizarreta Z
    Br J Haematol; 1987 Feb; 65(2):246-8. PubMed ID: 3548799
    [No Abstract]   [Full Text] [Related]  

  • 62. The facilitation of enduring engraftment of allogeneic bone marrow and avoidance of secondary disease in mice.
    Pierpaoli W; Maestroni GJ
    Cell Immunol; 1980 Jun; 52(1):62-72. PubMed ID: 6993015
    [No Abstract]   [Full Text] [Related]  

  • 63. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.
    Fossiez F; Djossou O; Chomarat P; Flores-Romo L; Ait-Yahia S; Maat C; Pin JJ; Garrone P; Garcia E; Saeland S; Blanchard D; Gaillard C; Das Mahapatra B; Rouvier E; Golstein P; Banchereau J; Lebecque S
    J Exp Med; 1996 Jun; 183(6):2593-603. PubMed ID: 8676080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transient engraftment of T cell-depleted allogeneic bone marrow in mice improves survival rate following lethal irradiation.
    Lapidot T; Singer TS; Reisner Y
    Bone Marrow Transplant; 1988 Mar; 3(2):157-64. PubMed ID: 3048480
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Total-body irradiation in preparation for marrow engraftment.
    Thomas ED; Storb R; Buckner CD
    Transplant Proc; 1976 Dec; 8(4):591-3. PubMed ID: 793115
    [No Abstract]   [Full Text] [Related]  

  • 70. Engraftment following T cell-depleted bone marrow transplantation. III. Differential effects of increased total-body irradiation on semiallogeneic and allogeneic recipients.
    Ferrara JL; Michaelson J; Burakoff SJ; Mauch P
    Transplantation; 1988 May; 45(5):948-52. PubMed ID: 3285542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.